GlassScriptPhysician profile
Patrick Quinn Dooling
NPI 1982119699
$1,397.96
in general payments reported to CMS, 2019-2025
12 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.95 · 2022: $269 · 2023: $353 · 2024: $388 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $329.34 | 2023-2025 | Sable, Coalition Agx, Fortify |
| Medtronic, INC. | $292.20 | 2022-2025 | Solitaire X, Cd Horizon Spinal System, Unid_pass |
| Stryker Corporation | $146.82 | 2022 | |
| Convatec INC. | $134.61 | 2024 | |
| Angiodynamics, INC. | $107.25 | 2025 | Angiovac |
| Arteriocyte Medical Systems, INC. | $105.58 | 2024-2025 | Magellan |
| Medical Device Business Services, INC. | $65.20 | 2021 | |
| Bioventus LLC | $51.73 | 2023-2024 | Bonescalpel & Sonicone (O.R.) |
| Ethicon US, LLC | $49.18 | 2021-2025 | Stratafix, Vistaseal |
| Kerecis Limited | $47.33 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Boston Scientific Corporation | $38.38 | 2025 | General - Pain Management |
| Acera Surgical, INC. | $30.34 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dooling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.